Carl Zeiss Meditec AG (AFXd)

FRAHealthcare

€25.21
+€0.37 (+1.5%)

April 7, 2026 at 13:06 UTC

Interactive Chart

AFXd
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

13:06:23 UTC

About Carl Zeiss Meditec AG

Name
Carl Zeiss Meditec AG
CEO
Andreas Pecher
Industry
Healthcare
Year Founded
2002
Employees
2,066

Carl Zeiss Meditec AG is a medical technology company focused on ophthalmic diagnostics, surgical visualization, and workflow software used in clinical practice. Systems pair optics with guidance features so examination and surgery follow consistent steps. Service plans and consumables are aligned to device cycles, keeping availability stable in clinics and operating rooms. Manufacturing and field support work inside a single quality framework, and documents are written for hospital audit without bespoke formats. Regional units manage training and market access, while core engineering remains centralized. The company sits at the junction of healthcare and information technology, where hardware and data must align. Product roadmaps emphasize incremental updates that protect continuity for clinicians and administrators.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 5 Buy, 12 Hold, 6 Sell
Buy5
Hold12
Sell6

Fundamentals & Financials

Revenue (TTM)
€2.2B
Net Income (TTM)
€141.2M
EPS (TTM)
€1.95
ROA (TTM)
4.08%
Current Ratio
2.35
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ3 2025
Revenue€627,545K
Cost of Sales€555,782K
Gross Profit€621,394K
Operating Income€144,114K
Net Income€51,810K
EPS€0.92

Technical Indicators

Carl Zeiss Meditec AG's Technical Indicators Summary

AFX.DE presents a neutral, mixed picture where short-term moving averages sit above the current price but longer-term EMAs remain notably higher, producing offset signals across timeframes. Momentum indicators are around neutral levels while the ADX reads unusually high, reflecting trend strength that contrasts with other neutral oscillators; volume via OBV is negative, offering little lift. ATR shows moderate volatility and pivot levels are holding, so overall the market lacks clear directional conviction. Technical takeaway: Neutral — short-term strength is offset by weaker longer-term breadth and negative volume.

Buy
5 signals
Neutral
12 signals
Sell
6 signals
Overall: Neutral52% Neutral signals
IndicatorValue
RSI (14)
47.22
Stochastic %K (14, 3, 3)
69.89
CCI (20)
75.64
WPR (14)
-23.45
Momentum (10)
1.26
MFI
65.70
MACD Level (12, 26)
-0.58
Bollinger Bands
$22.97 - $25.39
ATR (14)
$0.87 (3.50%)
ADX (14)
42.53
OBV
-13,596,892
Classic Pivot Point
$24.79
Fibonacci Pivot Point
$24.79
Simple Moving Averages
$24.18 - $25.94(5 indicators)
Exponential Moving Averages
$24.48 - $39.26(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

A noticeable 2.33% rise from yesterday’s close (24.84) has AFXd near 25.42. The wider group is going sideways (-0.36%), leaving AFXd to trade more on its own story. AFXd is carving out gains on its own story as the sector drifts, lifting relative to peers.

Price Change

from €24.84 close

+€0.39

Trading Volume

Below avg (227.4K)

177.4K

vs S&P 500 Today

Moderate Outperformance

+0.14%

52-Week Position

Near lows

6.5%

Updated: April 7, 2026 at 11:33 UTC

Quote Summary

OpenPrevious Close
€24.84€24.84
Day Range52 Week Range
€24.44 - €25€22.62 - €65.9
VolumeAvg. Volume
204.9K367.5K
Market CapP/E Ratio
€2.1B15.4